Market closed

ImmunoPrecise Antibodies/$IPA

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About ImmunoPrecise Antibodies

ImmunoPrecise Antibodies Ltd is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series proprietary and patented technologies. The company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges.

Ticker

$IPA
Trading on

Industry

Life Sciences Tools & Services

Headquarters

Victoria, Canada

Employees

87

IPA Metrics

BasicAdvanced
$17M
-
-$1.14
-
-
$17M
$1.50
$0.27
3.3M
2.322
1.99
44.734
51.457
-44.66%
-14.88%
-124.75%
0.646
0.5
0.77
-1.635
1.35%
195.88%
8.09%
22.34%

What the Analysts think about IPA

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for ImmunoPrecise Antibodies stock.

IPA Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

IPA Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $IPA

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs

What’s the current market cap for ImmunoPrecise Antibodies stock?

ImmunoPrecise Antibodies (IPA) has a market cap of $17M as of April 04, 2025.

What is the P/E ratio for ImmunoPrecise Antibodies stock?

The price to earnings (P/E) ratio for ImmunoPrecise Antibodies (IPA) stock is 0 as of April 04, 2025.

Does ImmunoPrecise Antibodies stock pay dividends?

No, ImmunoPrecise Antibodies (IPA) stock does not pay dividends to its shareholders as of April 04, 2025.

When is the next ImmunoPrecise Antibodies dividend payment date?

ImmunoPrecise Antibodies (IPA) stock does not pay dividends to its shareholders.

What is the beta indicator for ImmunoPrecise Antibodies?

ImmunoPrecise Antibodies (IPA) does not currently have a Beta indicator.